Evidence map›Paper›PMID 35352425›Full record

ArticleHead & neck2022

The implicated clinical factors for outcomes in 304 patients with salivary duct carcinoma: Multi-institutional retrospective analysis in Japan.

Kimihide Kusafuka, Yoko Sato, Eiji Nakatani, Satoshi Baba, Matsuyoshi Maeda, Koji Yamanegi, Kaori Ueda, Hiroshi Inagaki, Yoshiro Otsuki, Naoto Kuroda and 18 more

Abstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Head & neck, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Parotid Gland Tumors: Molecular Diagnostic Approaches.International journal of molecular sciences · 2024
    Review
  4. The extent of androgen receptor and HER2 expression allows for targeted therapy in most cases of salivary duct carcinoma: analysis of clinical and histopathological data in a tertiary care center.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2024
    Article
  5. Article
  6. Prognostic models for estimating survival of salivary duct carcinoma: a population-based study.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2023
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Kimihide KusafukaDepartment of Pathology, Shizuoka General Hospital, Shizuoka, Japan.ORCID 0000-0001-5315-2540
Yoko SatoDivision of Clinical Biostatistics, Research Support Center, Shizuoka General Hospital, Shizuoka, Japan.
Eiji NakataniDivision of Clinical Biostatistics, Research Support Center, Shizuoka General Hospital, Shizuoka, Japan.
Satoshi BabaDepartment of Diagnostic Pathology, Hamamatsu University School of Medicine Hospital, Shizuoka, Japan.
Matsuyoshi MaedaDepartment of Clinical Pathology, Toyohashi Municipal Hospital, Toyohashi, Japan.
Koji YamanegiDepartment of Pathology, Hyogo Medical College, Hyogo, Japan.
Kaori UedaDepartment of Pathology and Molecular Diagnostics, Nagoya City University, Nagoya, Japan.
Hiroshi InagakiDepartment of Pathology and Molecular Diagnostics, Nagoya City University, Nagoya, Japan.ORCID 0000-0001-6157-636X
Yoshiro OtsukiDepartment of Pathology, Seirei Hamamatsu General Hospital, Shizuoka, Japan.
Naoto KurodaDepartment of Diagnostic Pathology, Kobe Koudou Hospital Center, Kobe, Japan.
Kensuke SuzukiDepartment of Otolaryngology - Head and Neck Surgery, Kansai Medical University, Osaka, Japan.
Hiroshi IwaiDepartment of Otolaryngology - Head and Neck Surgery, Kansai Medical University, Osaka, Japan.
Yoshiaki ImamuraDivision of Diagnostic Pathology/Surgical Pathology, University of Fukui Hospital, Fukui, Japan.
Junya ItakuraDepartment of Anatomic Pathology, Kurashiki Central Hospital, Okayama, Japan.
Shoji YamanakaDepartment of Diagnostic Pathology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Hideaki TakahashiDepartment of Otorhinolaryngology - Head and Neck Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan.ORCID 0000-0003-3783-9961
Ichiro ItoDepartment of Diagnostic Pathology, Nagano Red Cross Hospital, Nagano, Japan.
Takumi AkashiDivision of Surgical Pathology, Tokyo Medical and Dental University Hospital, Tokyo, Japan.
Tsutomu DaaDepartment of Diagnostic Pathology, Oita University, Oita, Japan.
Mei HamadaDepartment of Diagnostic Pathology, Saitama Medical University International Medical Center, Saitama, Japan.
Masanori YasudaDepartment of Diagnostic Pathology, Saitama Medical University International Medical Center, Saitama, Japan.
Ryo KawataDepartment of Otorhinolaryngology - Head and Neck Surgery, Osaka Medical and Pharmaceutical University, Osaka, Japan.
Hidetaka YamamotoDepartment of Anatomic Pathology, Kyushu University, Fukuoka, Japan.
Yuri TachibanaDepartment of Pathology, Nagasaki University, Nagasaki, Japan.
Junya FukuokaDepartment of Pathology, Nagasaki University, Nagasaki, Japan.
Aya MuramatsuDepartment of Pathology, Shizuoka General Hospital, Shizuoka, Japan.
Kazumori AraiDepartment of Pathology, Shizuoka General Hospital, Shizuoka, Japan.
Makoto SuzukiDepartment of Pathology, Shizuoka General Hospital, Shizuoka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSalivary duct carcinoma (SDC) is a high-grade salivary malignancy that frequently occurs as the carcinomatous component of carcinoma ex pleomorphic adenoma. We herein examined the clinical factors affecting outcomes in a large cohort of SDC.

methodsWe selected 304 SDC cases and investigated clinical characteristics and the factors affecting outcomes.

resultsThe median age of the cases examined was 68 years, the most common primary site was the parotid gland (238 cases), and there was a male predominance (M/F = 5:1). Outcomes were significantly worse when the primary tumor site was the minor salivary glands (SG) than when it was the major SG. Outcomes were also significantly worse in pN(+) cases (161 cases) than in pN0 cases, particularly those with a metastatic lymph node number ≥11. The cumulative incidence of relapse and distant metastases was significantly higher in stage IV cases than in stage 0-III cases.

conclusionsThe absolute number of lymph node metastases, higher stages, and the minor SG as the primary tumor site were identified as factors affecting the outcome of SDC.

Indexed as

Adenoma, PleomorphicCarcinoma, DuctalSalivary Gland NeoplasmsAgedFemaleHumansJapanMaleNeoplasm Recurrence, LocalRetrospective StudiesSalivary Ductscompeting-risk modelJapanese patientoutcomessalivary duct carcinoma

Identifiers

PMID35352425
PMCPMC9311811

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.